X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (214) 214
Publication (16) 16
Magazine Article (7) 7
Conference Proceeding (4) 4
Book Review (3) 3
Book / eBook (1) 1
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105) 105
female (68) 68
male (68) 68
cardiac & cardiovascular systems (66) 66
atrial fibrillation (59) 59
aged (56) 56
middle aged (54) 54
stroke (40) 40
index medicus (38) 38
anticoagulants (33) 33
care and treatment (32) 32
risk factors (31) 31
atrial fibrillation - drug therapy (29) 29
warfarin (28) 28
drug therapy (27) 27
mortality (27) 27
anticoagulants - therapeutic use (26) 26
prevention (26) 26
treatment outcome (24) 24
atrial fibrillation - complications (23) 23
stroke - prevention & control (22) 22
cardiac arrhythmia (21) 21
cardiovascular (21) 21
anticoagulation (20) 20
follow-up studies (20) 20
abridged index medicus (19) 19
adult (19) 19
electrocardiography (19) 19
heart failure (18) 18
warfarin - therapeutic use (18) 18
aged, 80 and over (17) 17
aspirin (17) 17
cardiology (16) 16
medicine, general & internal (16) 16
stroke - etiology (14) 14
anticoagulants - adverse effects (13) 13
health aspects (13) 13
therapy (13) 13
heart attack (12) 12
internal medicine (12) 12
peripheral vascular disease (12) 12
risk (12) 12
risk assessment (12) 12
aspirin - therapeutic use (11) 11
clinical trials (11) 11
fibrillation (11) 11
heart attacks (11) 11
medical and health sciences (11) 11
medicin och hälsovetenskap (11) 11
prognosis (11) 11
stroke prevention (11) 11
analysis (10) 10
animals (10) 10
apixaban (10) 10
cardiac patients (10) 10
cardiology and cardiovascular medicine (10) 10
cardiovascular disease (10) 10
dabigatran (10) 10
hemorrhage - chemically induced (10) 10
management (10) 10
pacemaker, artificial (10) 10
proportional hazards models (10) 10
pyrazoles - therapeutic use (10) 10
pyridones - therapeutic use (10) 10
research (10) 10
trial (10) 10
atrial fibrillation - therapy (9) 9
double-blind method (9) 9
heart (9) 9
patient outcomes (9) 9
randomized controlled trials as topic (9) 9
survival (9) 9
thromboembolism (9) 9
thromboembolism - prevention & control (9) 9
antithrombotic therapy (8) 8
aspirin - adverse effects (8) 8
cardioversion (8) 8
evaluation (8) 8
myocardial-infarction (8) 8
patients (8) 8
warfarin - adverse effects (8) 8
captopril (7) 7
drug therapy, combination (7) 7
embolism (7) 7
hematology (7) 7
hemodynamics (7) 7
incidence (7) 7
medical research (7) 7
medicine & public health (7) 7
morbidity (7) 7
pyrazoles - adverse effects (7) 7
pyridones - adverse effects (7) 7
time factors (7) 7
transluminal angioplasty (7) 7
usage (7) 7
age factors (6) 6
anti-arrhythmia agents - therapeutic use (6) 6
arrhythmias, cardiac - physiopathology (6) 6
atrial fibrillation - diagnosis (6) 6
atrial fibrillation - epidemiology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Flaker and Greg
07/2018, ISBN 9780323554299, 203
eBook
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 11, pp. 981 - 992
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A15177 - A15177
IntroductionAmiodarone can cause many severe multi-organ toxicities. Strategies to ensure safe use include the performance of lung, liver, and thyroid studies... 
Journal Article